Skip to content

Drug interactions

Ruxolitinib + Valproic acid

Severity: Minor

Ruxolitinib and Valproic acid: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Valproate is not a recognized CYP3A4 inhibitor, so a clinically meaningful rise in ruxolitinib exposure is unlikely. Both drugs can contribute to cytopenias, notably thrombocytopenia. The interaction is mainly pharmacodynamic.

What this interaction means in plain words

Ruxolitinib and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ruxolitinib belongs to Oncology; Valproic acid belongs to Central Nervous System.

Evidence level: Low

Why it happens

No established pharmacokinetic mechanism; additive myelosuppressive effects on platelets are possible.

What to do

Monitor the complete blood count, especially platelets, during combined therapy. Adjust ruxolitinib according to labeled platelet-based guidance.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ruxolitinib and Valproic acid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ruxolitinib with Valproic acid?

MediHelp rates the interaction as minor. Ruxolitinib and Valproic acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Valproate is not a recognized CYP3A4 inhibitor, so a clinically meaningful rise in ruxolitinib exposure is unlikely. Both drugs can contribute to cytopenias, notably thrombocytopenia. The interaction is mainly pharmacodynamic.

How serious is the interaction between Ruxolitinib and Valproic acid?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor the complete blood count, especially platelets, during combined therapy. Adjust ruxolitinib according to labeled platelet-based guidance.

What other medicines interact with Valproic acid?

MediHelp also lists interactions of Valproic acid with, for example, Ertapenem, Imipenem / cilastatin / relebactam, Imipenem / cilastatin. The full list is on the Valproic acid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in